Startups
We want to shift the paradigm in drug delivery systems. Mercury Bio has invented a drug delivery platform designed to unleash the potential of RNA and small-molecule drugs using reliable, cell-specific delivery—targeting only the cells that need therapy and working with the body to bypass immune reactions. Not only will our technology boost patient outcomes, it will help drug developers quicken products to market by reducing many of the obstacles, delays, and risks encountered by traditional drug delivery systems, spreading the viable reach of new medications in the process. By advancing drug efficacy, lowering costs, reducing side effects, and shortening time to market, we aim to unlock the potential of new therapies and help make the world’s most advanced medicines more accessible to everyone.
Overview
Location
United States, New Mexico, Santa Fe
Employees
11-50
Total raised
$2M
Founded date
2020
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 30, 2023 | Mercury Bio Closes $2M Early Funding | SANTA FE, NM, Mercury Bio, a biotech company, concluded a $2M seed funding round. >> Click here for more funding data on Mercury Bio >> To export Mercury Bio funding data to PDF and Excel, click here Mercury Bio, a Santa ... |
| Aug 30, 2023 | Biotech startup Mercury Bio raises $2 million to develop next-generation drug delivery platform | Mercury Bio, a Santa Fe, NM-based biotech startup developing targeted molecular drug delivery technology, has closed $2 million in seed funding to expand its next-generation biomolecular drug delivery platform. The seed funding, which was i... |
| Mercury Bio | “With a focus on advanced bio-molecular drug delivery systems, Mercury Bio is developing the therapeutic technologies to help more people heal more effectively.” |
Reviews 0
FAQ about Mercury Bio
When was Mercury Bio founded?
Mercury Bio was founded in 2020.
How much funding has Mercury Bio raised?
Mercury Bio has raised $2M in total across 1 funding round.
What has the press written about Mercury Bio?
Parsers VC has collected 4 articles mentioning Mercury Bio, among them “Mercury Bio Closes $2M Early Funding” (Aug 30, 2023) and “Biotech startup Mercury Bio raises $2 million to develop next-generation drug delivery platform” (Aug 30, 2023).
Is Mercury Bio still active?
Yes, Mercury Bio is active; its latest activity on Parsers VC dates from Aug 30, 2023.